FoxP3 gene promoter polymorphism affects susceptibility to preeclampsia.

Hum Immunol

Molecular Medicine Research Center, Department of Immunology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address:

Published: December 2016

Background: Preeclampsia (PE) is a multifactorial pregnancy disorder and is a major cause of maternal morbidity and mortality. Despite intense study, the pathophysiology of preeclampsia remains enigmatic. Recent studies have reported that regulatory T cells (Tregs) is linked with PE. It is well identified that FoxP3/Scurfin is involved in development and function of Tregs. However, the association between PE and the FoxP3 gene polymorphism has not been sufficiently investigated. In this study, we hypothesized that polymorphisms of the FoxP3 may be related to PE.

Methods: We assessed the relationship between four single-nucleotide polymorphisms (SNPs) in the FoxP3 genes with sequence-specific primers (PCR-SSP) in 81 PE patients and 90 age-matched controls.

Result: We identified significant difference of rs4824747 GG genotype frequency between the PE and control groups. Women with GG genotypes exhibited higher (OR=6.25, 95% CI=2.63-14.85; P<0.0001) risk of developing PE. None of the other investigated SNPs (rs2232365, rs3761547 and rs3761548) showed significant association with PE.

Conclusion: We suggest that FoxP3 polymorphisms (rs4824747) could be a potential contributor for the development of PE in Iranian women.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2016.09.001DOI Listing

Publication Analysis

Top Keywords

foxp3 gene
8
foxp3
4
gene promoter
4
promoter polymorphism
4
polymorphism susceptibility
4
susceptibility preeclampsia
4
preeclampsia background
4
background preeclampsia
4
preeclampsia multifactorial
4
multifactorial pregnancy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!